Scinai Immunotherapeutics (SCNI) Times Interest Earned (2014 - 2022)
Scinai Immunotherapeutics' (SCNI) quarterly Times Interest Earned came in at $0.85 in Q3 2022, down 71.2% year-on-year from $2.94 in Q3 2021, and up 194.4% quarter-over-quarter from -$0.9 in Q2 2022.
Scinai Immunotherapeutics (SCNI) Times Interest Earned (2014 - 2022) Analysis & Trends
Scinai Immunotherapeutics has disclosed Times Interest Earned across 9 years of filings, most recently posting $0.85 for Q3 2022.
- Times Interest Earned for Q3 2022 came in at $0.85, down 71.2% year-over-year; the trailing twelve-month figure through Jun 2023 was -$4.37 (down 694.12% YoY), and the FY2021 annual result was $1.0, up 313.09% from the prior year.
- Times Interest Earned came in at $0.85 for Q3 2022 at Scinai Immunotherapeutics, up from -$0.9 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $135.47 in Q1 2020 to a low of -$193.07 in Q3 2020.
- The 5-year median for Times Interest Earned is $2.91 (2021), against an average of -$2.2.
- Peak annual rise in Times Interest Earned reached 3724.82% in 2020, while the deepest fall reached 713.18% in 2020.
- Scinai Immunotherapeutics' Times Interest Earned stood at $3.65 in 2018, then surged by 762.11% to $31.49 in 2019, then plunged by 50.15% to $15.7 in 2020, then sank by 130.47% to -$4.78 in 2021, then jumped by 117.68% to $0.85 in 2022.
- The last three Times Interest Earned figures came in at $0.85 (Q3 2022), -$0.9 (Q2 2022), and $3.55 (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Scinai Immunotherapeutics | 3.02 Bn | 988.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 0.85 |
| Jun 30, 2022 | -0.90 |
| Mar 31, 2022 | 3.55 |
| Dec 31, 2021 | -4.78 |
| Sep 30, 2021 | 2.94 |
| Jun 30, 2021 | 2.88 |
| Mar 31, 2021 | 2.58 |
| Dec 31, 2020 | 15.70 |
| Sep 30, 2020 | -193.07 |
| Mar 31, 2020 | 135.47 |
| Sep 30, 2019 | 31.49 |
| Jun 30, 2019 | 0.10 |
| Mar 31, 2019 | 3.54 |
| Sep 30, 2018 | 3.65 |
| Jun 30, 2018 | -47.22 |
| Mar 31, 2018 | 8.02 |
| Mar 31, 2017 | 0.33 |
| Mar 31, 2016 | 6.72 |
| Sep 30, 2015 | -442.60 |
| Dec 31, 2014 | -495.00 |